E002-1315 Screening compound: 1-(2-methoxy-5-methylphenyl)-3-[5-(pyrrolidin-1-yl)-1,3,4-thiadiazol-2-yl]urea

E002-1315 Screening compound: 1-(2-methoxy-5-methylphenyl)-3-[5-(pyrrolidin-1-yl)-1,3,4-thiadiazol-2-yl]urea
E002-1315 Screening compound: 1-(2-methoxy-5-methylphenyl)-3-[5-(pyrrolidin-1-yl)-1,3,4-thiadiazol-2-yl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound E002-1315
1-(2-methoxy-5-methylphenyl)-3-[5-(pyrrolidin-1-yl)-1,3,4-thiadiazol-2-yl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E002-1315

Molecular Formula

C15H19N5O2S (C15 H19 N5 O2 S)

Compound Name

1-(2-methoxy-5-methylphenyl)-3-[5-(pyrrolidin-1-yl)-1,3,4-thiadiazol-2-yl]urea

IUPAC name

1-(2-methoxy-5-methylphenyl)-3-[5-(pyrrolidin-1-yl)-134-thiadiazol-2-yl]urea

SMILES

Cc(cc1)cc(NC(Nc2nnc(N3CCCC3)s2)=O)c1OC

InChI

InChI=1S/C15H19N5O2S/c1-10-5-6-12(22-2)11(9-10)16-13(21)17-14-18-19-15(23-14)20-7-3-4-8-20/h5-6,9H,3-4,7-8H2,1-2H3,(H2,16,17,18,21)

InChI Key

LRNCGMQRHCWSMH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14835148

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

333.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.324

Distribution Coefficient, logD

3.324

Water Solubility, LogSw

-3.55

Polar Surface Area

66.652

Acid Dissociation Constant (pKa)

12.50

Base Dissociation Constant (pKb)

-0.69

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

E002-1315 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

C-Met Library (15277 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E002-1315 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E002-1315?
Check Price and Availability of E002-1315, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E002-1315 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E002-1315
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E002-1315
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E002-1315 available by request